Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	5.85	81.02	76.54
Graham Fair Price	-10.82	20.59	23.09
PEG	519.35	-0.99	0.16
Price/Book	-14.87	2.29	2.69
Price/Cash Flow	-48.55	33.39	64.90
Prices/Earnings	31.65	21.98	16.70
Price/Sales	-11.50	16.67	18.83
Price/FCF	-48.55	33.39	64.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.53	0.76	0.70
Operating Margin	21.02	0.18	0.15
ROA	-35.47	0.02	0.03
ROE	0.04	0.03	-35.34
ROIC	0.02	0.02	1.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.10	-93.94
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	0.30	1001.52
EPS QOQ	1.05	-0.22	-78.74
FCF QOQ	-0.28	0.85	201.77
Revenue QOQ	-0.01	0.08	440.93
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	118.59	41795736357.07
Days Sales Outstanding (DSO)	42.08	41.60	-1.15
Inventory Turnover	317188843.00	0.76	-100.00
Debt/Capitalization	< 0.005	< 0.005	-14.61
Quick Ratio	4.26	4.26	-0.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.24	26.88	10.89
Cash	21.07	23.89	13.39
Capex	-0.06	-0.06	-6.98
Free Cash Flow	1.01	1.85	83.50
Revenue	3.47	3.70	6.67
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.38	4.46	1.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.68	-8.56	-50.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating